Snus professor took tobacco pay, Ekot probes disclosure gaps in Sweden’s nicotine debate

• Ekot reports that professor Fredrik Nyström took paid assignments from a tobacco-industry company while arguing publicly that snus can reduce smoking.
• Nyström told Ekot he openly declares conflicts of interest when relevant and said he saw no problem.
• The case raises questions about how Swedish universities, regulators and media handle disclosure rules for nicotine researchers.
• Sweden’s status as a low-smoking country is often cited in defence of snus, giving industry-linked voices a ready-made policy opening.

Professor Fredrik Nyström, one of the better-known Swedish voices arguing that snus helps smokers quit cigarettes, also took paid assignments from a tobacco-industry company, according to Sveriges Radio Ekot reports. Ekot’s investigation, part of its series Nikotinkriget, also says Nyström lectured at international events that he himself believes may have had links to the tobacco industry.

Nyström told Ekot that he openly declares conflicts of interest when there is a question of bias and said he saw no problem with the arrangement. The immediate issue is not whether snus carries lower health risks than smoking; Swedish policymakers, researchers and public-health agencies have argued over that for years. The harder question is who gets to frame that argument in public, and on what terms. When a professor appears in media or policy debate as an academic authority, paid work from the same industry that benefits from the message changes the transaction, even if the facts cited are not false.

That matters in Sweden because snus occupies a special place in the country’s tobacco politics. Sweden has one of Europe’s lowest smoking rates, and supporters of looser nicotine policy routinely point to snus as part of the explanation. That gives tobacco and nicotine companies a clear incentive to amplify researchers and clinicians willing to present snus as a public-health asset rather than a product with its own dependency and health costs. A country that treats its smoking statistics as proof of concept also creates a market for expert validation.

Ekot’s reporting points to a familiar blind spot in Swedish institutional life: disclosure often depends on the individual rather than on any visible, enforceable system. Universities have rules on conflicts of interest, but public debate runs through newspaper op-eds, radio interviews, conferences and advisory roles where standards vary and readers rarely see a full ledger of payments, speaking fees or sponsored travel. A professor can be introduced by title alone while the commercial relationships sit elsewhere, disclosed partially, late, or only when a journalist asks. The result is that the audience is left to assess independence after the argument has already done its work.

The case also reaches beyond one academic. Sweden’s nicotine debate includes researchers, physicians, consultants, advocacy groups and industry-funded platforms, all operating in a field where regulation shifts market share between cigarettes, snus, nicotine pouches and pharmaceutical cessation products. Every change in tax, warning labels, flavour rules or sales restrictions creates winners and losers. In that setting, expert testimony is not just commentary; it is part of the market.

Ekot’s story does not show that Swedish tobacco policy is written by industry-paid academics. It shows something narrower and more concrete: one prominent professor defending snus in public while also taking money from the business that sells nicotine. In Sweden’s public-health debate, the title “professor” still arrives before the invoice.

Källor: Sveriges Radio Ekot